BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29348856)

  • 41. Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer.
    Kim DI; Kim E; Kim YA; Cho SW; Lim JA; Park YJ
    Endocrinol Metab (Seoul); 2016 Sep; 31(3):469-475. PubMed ID: 27491720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Distinct Impact of TAM Infiltration on the Prognosis of Patients With Cardia and Non-Cardia Gastric Cancer and Its Association With
    Liu M; Zhang L; Zhou Q; Wang Y; Sun Q; Ren X
    Front Oncol; 2021; 11():737061. PubMed ID: 34926251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer.
    Chen XJ; Han LF; Wu XG; Wei WF; Wu LF; Yi HY; Yan RM; Bai XY; Zhong M; Yu YH; Liang L; Wang W
    J Cancer; 2017; 8(18):3868-3875. PubMed ID: 29151975
    [No Abstract]   [Full Text] [Related]  

  • 44. The prognostic value of CD8
    Jin Q; Jiang H; Yue N; Zhang L; Li C; Dong C; Zeng P; Yue L; Wu C
    Leuk Lymphoma; 2024 Apr; 65(4):472-480. PubMed ID: 38198635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer.
    Maisel BA; Yi M; Peck AR; Sun Y; Hooke JA; Kovatich AJ; Shriver CD; Hu H; Nevalainen MT; Tanaka T; Simone N; Wang LL; Rui H; Chervoneva I
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new method for predicting the prognosis of colorectal cancer patients through a combination of multiple tumor-associated macrophage markers at the invasive front.
    Wang X; Yuwen TJ; Zhong Y; Li ZG; Wang XY
    Heliyon; 2023 Feb; 9(2):e13211. PubMed ID: 36798759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis.
    Ni C; Yang L; Xu Q; Yuan H; Wang W; Xia W; Gong D; Zhang W; Yu K
    J Cancer; 2019; 10(19):4463-4472. PubMed ID: 31528210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.
    Majid U; Bergsland CH; Sveen A; Bruun J; Eilertsen IA; Bækkevold ES; Nesbakken A; Yaqub S; Jahnsen FL; Lothe RA
    Cell Oncol (Dordr); 2024 Feb; ():. PubMed ID: 38407700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma.
    Yu Y; Ke L; Lv X; Ling YH; Lu J; Liang H; Qiu W; Huang X; Liu G; Li W; Guo X; Xia W; Xiang Y
    Cancer Manag Res; 2018; 10():1935-1946. PubMed ID: 30022852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness.
    Takeuchi H; Tanaka M; Tanaka A; Tsunemi A; Yamamoto H
    Oncol Lett; 2016 May; 11(5):3403-3408. PubMed ID: 27123124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer.
    Sumitomo R; Hirai T; Fujita M; Murakami H; Otake Y; Huang CL
    Exp Ther Med; 2019 Dec; 18(6):4490-4498. PubMed ID: 31777551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human breast cancer cells educate macrophages toward the M2 activation status.
    Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
    Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
    Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
    J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients.
    Ni YH; Ding L; Huang XF; Dong YC; Hu QG; Hou YY
    Tumour Biol; 2015 Jul; 36(7):5291-8. PubMed ID: 25666753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Prognostic and Clinical Value of Tumor-Associated Macrophages in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.
    Wang C; Lin Y; Zhu H; Zhou Y; Mao F; Huang X; Sun Q; Li C
    Front Oncol; 2022; 12():905846. PubMed ID: 35847911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A reappraisal of macrophage polarization in glioblastoma: Histopathological and immunohistochemical findings and review of the literature.
    Mignogna C; Signorelli F; Vismara MF; Zeppa P; Camastra C; Barni T; Donato G; Di Vito A
    Pathol Res Pract; 2016 Jun; 212(6):491-9. PubMed ID: 27101800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
    Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
    Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TIE2-expressing monocytes and M2-polarized macrophages impact survival and correlate with angiogenesis in adenocarcinoma of the pancreas.
    Atanasov G; Pötner C; Aust G; Schierle K; Dietel C; Benzing C; Krenzien F; Bartels M; Eichfeld U; Schmelzle M; Bahra M; Pascher A; Wiltberger G
    Oncotarget; 2018 Jul; 9(51):29715-29726. PubMed ID: 30038715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of density of tumor-associated macrophages using CD163 in histological grades of oral squamous cell carcinoma, an immunohistochemical study.
    Chaudhari N; Prakash N; Pradeep GL; Mahajan A; Lunawat S; Salunkhe V
    J Oral Maxillofac Pathol; 2020; 24(3):577. PubMed ID: 33967504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.